Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
Azithromycin
Medis Pharma Pty Ltd
Medicine Registered
Azithromycin-GA 500mg PI200313A Azithromycin-GA PRODUCT INFORMATION NAME OF THE MEDICINE Azithromycin (as monohydrate). The chemical name for azithromycin monohydrate is 9-deoxo-9a- aza-9a-methyl-9a-homoerythromycin A monohydrate. The structural formula of azithromycin monohydrate is: .H 2 O C 38 H 72 N 2 O 12 .H 2 O Molecular weight: 767.01 Cas No.: 121470-24-4 DESCRIPTION Azithromycin monohydrate is a white or almost-white powder. Azithromycin-GA tablets contain 500 mg of azithromycin (as monohydrate). The tablets also contain the following excipients: calcium hydrogen phosphate anhydrous, pregelatinised maize starch, croscarmellose sodium, sodium lauryl sulfate, magnesium stearate and Opadry AMB Complete film coating system OY-B-28920 White (Proprietary Ingredient ID: 4271). The tablets are gluten free. PHARMACOLOGY MECHANISM OF ACTION Azithromycin acts by binding to the 50S ribosomal subunit of susceptible organisms, thus interfering with microbial protein synthesis. Nucleic acid synthesis is not affected. MICROBIOLOGY AZITHROMYCIN DEMONSTRATES ACTIVITY _IN VITRO_ AGAINST A WIDE RANGE OF BACTERIA INCLUDING: GRAM-POSITIVE AEROBIC BACTERIA. _Staphylococcus aureus_, _Streptococcus pyogenes_ (group A beta-haemolytic Streptococci), _Streptococcus pneumoniae_, alpha-haemolytic Streptococci AZITHROMYCIN-GA – Product information 2 Azithromycin-GA 500mg PI200313A (viridans group) and other Streptococci, and _Corynebacterium diphtheriae_. Azithromycin demonstrates cross resistance with erythromycin resistant gram-positive strains, including _Streptococcus faecalis _(enterococcus) and most strains of methicillin resistant Staphylococci. GRAM-NEGATIVE AEROBIC BACTERIA. _Haemophilus influenzae _(including beta-lactamase producing _Haemophilus influenzae_), _Haemophilus parai Preberite celoten dokument